-
LHDXQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Lucira Health (LHDXQ)
Company Profile
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 41.72 mm | 41.72 mm | 41.72 mm | 41.72 mm | 41.72 mm | 41.72 mm |
Cash burn (monthly) | 11.73 mm | 6.68 mm | 42.28 mm | 11.91 mm | 9.41 mm | 6.86 mm |
Cash used (since last report) | 314.21 mm | 179.08 mm | 1.13 bn | 319.22 mm | 252.23 mm | 183.86 mm |
Cash remaining | -272.49 mm | -137.36 mm | -1.09 bn | -277.50 mm | -210.51 mm | -142.14 mm |
Runway (months of cash) | -23.2 | -20.6 | -25.8 | -23.3 | -22.4 | -20.7 |
13F holders | Current |
---|---|
Total holders | 7 |
Opened positions | 3 |
Closed positions | 24 |
Increased positions | 1 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 1.44 bn |
Total shares | 10.51 mm |
Total puts | 0.00 |
Total calls | 12.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Eclipse Ventures | 6.22 mm | $1.43 bn |
Eclipse GP III | 4.18 mm | $0.00 |
Simplex Trading | 74.76 k | $17.00 k |
Resolute Advisors | 22.80 k | $5.24 mm |
BCS Barclays | 2.91 k | $1.00 k |
Clear Street | 1.00 k | $0.00 |
FNY Investment Advisers | 0.00 | $0.00 |